{"id":62643,"date":"2026-02-13T01:06:23","date_gmt":"2026-02-13T00:06:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/"},"modified":"2026-02-13T01:06:23","modified_gmt":"2026-02-13T00:06:23","slug":"ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/","title":{"rendered":"GE HealthCare announces cash dividend for first quarter of 2026"},"content":{"rendered":"<div>\n<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026.<\/p>\n<p>\n<b>About GE HealthCare Technologies Inc.<\/b><\/p>\n<p>\nGE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world\u2019s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.<\/p>\n<p>\nGE HealthCare is proud to be among <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ffortune.com%2Franking%2Fworlds-most-admired-companies%2F&amp;esheet=54424240&amp;newsitemid=20260212605971&amp;lan=en-US&amp;anchor=2026+Fortune+World%26%238217%3Bs+Most+Admired+Companies%26%238482%3B.&amp;index=1&amp;md5=2245d0972b1aacc97ddc2240d72096fe\" rel=\"nofollow\" shape=\"rect\">2026 <i>Fortune<\/i> World\u2019s Most Admired Companies\u2122.<\/a><\/p>\n<p>\nFollow us on<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fgehealthcare&amp;esheet=54424240&amp;newsitemid=20260212605971&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=4031c03910118490f12f9ac69d34964a\" rel=\"nofollow\" shape=\"rect\"> LinkedIn<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FGEHealthCare%2F&amp;esheet=54424240&amp;newsitemid=20260212605971&amp;lan=en-US&amp;anchor=Facebook&amp;index=3&amp;md5=81306e28c6918758ea4018e149f8ba5b\" rel=\"nofollow\" shape=\"rect\">Facebook<\/a>, <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fgehealthcare%2F&amp;esheet=54424240&amp;newsitemid=20260212605971&amp;lan=en-US&amp;anchor=Instagram&amp;index=4&amp;md5=fbca4c39f3544907cc91f4112f03ea67\" rel=\"nofollow\" shape=\"rect\">Instagram<\/a>, or visit our website for our <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Fabout%2Fnewsroom&amp;esheet=54424240&amp;newsitemid=20260212605971&amp;lan=en-US&amp;anchor=latest+news&amp;index=5&amp;md5=8702a4dc1180696b81848a7fa2d10584\" rel=\"nofollow\" shape=\"rect\">latest news<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.gehealthcare.com%2Finsights%3FshowPopup%3Dfalse&amp;esheet=54424240&amp;newsitemid=20260212605971&amp;lan=en-US&amp;anchor=perspectives&amp;index=6&amp;md5=ea880fa593fc638fe4cbbcb097a45595\" rel=\"nofollow\" shape=\"rect\">perspectives<\/a>.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor Relations Contact:<\/b><br \/>Carolynne Borders<br \/>\n<br \/>+1 631 662 4317<br \/>\n<br \/><a target=\"_blank\" href=\"mai&#108;&#116;&#111;&#x3a;&#x63;&#x61;&#x72;&#x6f;&#x6c;ynn&#101;&#46;&#98;&#111;&#x72;&#x64;&#x65;&#x72;&#x73;&#x40;geh&#101;&#97;&#108;&#x74;&#x68;&#x63;&#x61;&#x72;&#x65;&#46;co&#109;\" rel=\"nofollow\" shape=\"rect\">&#99;&#x61;&#x72;o&#108;&#x79;n&#110;&#x65;&#x2e;b&#111;&#x72;d&#101;&#x72;&#x73;&#64;&#103;&#x65;h&#101;&#x61;&#x6c;&#116;&#104;&#x63;a&#114;&#x65;&#x2e;&#99;&#x6f;&#x6d;<\/a><\/p>\n<p>\n<b>Media Contact:<\/b><br \/>Jennifer Fox<br \/>\n<br \/>+ 1 414 530 3027<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#105;&#108;t&#x6f;&#x3a;&#x6a;&#101;nn&#x69;&#x66;&#101;&#114;&#46;&#x72;&#x2e;&#x66;&#111;x&#64;&#x67;&#x65;&#104;&#101;a&#x6c;&#x74;&#x68;&#99;ar&#x65;&#x2e;&#99;&#111;m\" rel=\"nofollow\" shape=\"rect\">&#x6a;&#x65;&#x6e;&#x6e;&#105;&#102;er&#46;&#x72;&#x2e;&#x66;&#x6f;&#120;&#64;geh&#x65;&#x61;&#x6c;&#x74;&#104;&#99;&#97;re&#x2e;&#x63;&#x6f;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHICAGO&#8211;(BUSINESS WIRE)&#8211;The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62643","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GE HealthCare announces cash dividend for first quarter of 2026 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GE HealthCare announces cash dividend for first quarter of 2026 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHICAGO&#8211;(BUSINESS WIRE)&#8211;The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-13T00:06:23+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"GE HealthCare announces cash dividend for first quarter of 2026\",\"datePublished\":\"2026-02-13T00:06:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\\\/\"},\"wordCount\":193,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\\\/\",\"name\":\"GE HealthCare announces cash dividend for first quarter of 2026 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2026-02-13T00:06:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GE HealthCare announces cash dividend for first quarter of 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GE HealthCare announces cash dividend for first quarter of 2026 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/","og_locale":"en_US","og_type":"article","og_title":"GE HealthCare announces cash dividend for first quarter of 2026 - Pharma Trend","og_description":"CHICAGO&#8211;(BUSINESS WIRE)&#8211;The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per share of Common Stock for the first quarter of 2026 payable on May 15, 2026, to all shareholders of record as of April 3, 2026. About GE HealthCare Technologies Inc. GE HealthCare is a leading ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/","og_site_name":"Pharma Trend","article_published_time":"2026-02-13T00:06:23+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"GE HealthCare announces cash dividend for first quarter of 2026","datePublished":"2026-02-13T00:06:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/"},"wordCount":193,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/","url":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/","name":"GE HealthCare announces cash dividend for first quarter of 2026 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2026-02-13T00:06:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ge-healthcare-announces-cash-dividend-for-first-quarter-of-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"GE HealthCare announces cash dividend for first quarter of 2026"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62643","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62643"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62643\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62643"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62643"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62643"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}